Welcome
PPM

Contents

 
  Search

 


 

contents.gif (1945 bytes)
  May 2009







Application of Spinal Segmental Physiology to Evaluating Chronic Pain


A simple dermatomal screening process is used to help isolate the location of an offending segment when spinal 'segmental facilitation' is the cause of a chronic pain disorder.

by John L. Beck, MD


Facility Profile: Casa Palmera
Casa Palmera has become a model center for the treatment of comorbid chronic pain, substance dependence, eating disorders, and emotional trauma by bringing together the best of Eastern and Western medicine with neuroscience.
by Joseph Shurman, MD; David Bergman, MD, DLFAPA; George Koob, PhD; Michael Lardon, MD; and Phyllis Meagher, MBA

Pain Management in a Palliative Care Setting

by Leonard B. Goldstein, DDS, PhD and Scott Falkowitz, BS, OMS III

Precursor Amino Acid Therapy
A new entry into pain management.
by Forest Tennant, MD, DrPH

Opioid Treatment Longevity Study: Interim Report

by Forest Tennant, MD, DrPH

Dental Consequences of Pain Management
Pain and its associated issues can contribute to oral bacterial growth and inflammatory processes which, in turn, affects systemic health conditions.
by Robert Reed, DDS, QME; David Schames, BA; Y. Dov Prero, BA, MEd; and Deborah Kheradyar, BS


Publisher's Message: The PPM Calendar of Articles Is in Work

by Marvin Rosenfeld

Clinical Bioethics: Intellectual and Moral Tasks in Intersection: Part 2
Information, Consent, Autonomy, and Agency
by Mark V. Boswell, MD, PhD; Jill Kaspar; and James Giordano, PhD

Prolotherapy: Prolotherapy for Sacroiliac Joint Laxity
Using the prone posterior iliac glide test, the practitioner can clinically detect instability of the sacroiliac joint and confirm restoration of stability following prolotherapy.
by Dr. R. C. Sweeting, F.R.C.S.(C), F.R.A.C.S.(ORTH)

Laser Therapy: Neuroma Pain of the Foot Successfully Managed with Laser Therapy
Using exclusive laser treatment, a foot neuroma caseùfor a patient that was not effectively treated by conventional medicineùwas resolved to a pain-free state over the course of six weeks.
by John L. Stump, DC, PhD, EdD

Fibromyalgia: Milnacipran: A New Treatment Option for Fibromyalgia

by Philip J. Mease, MD


©2007 Copyright. PPM Communications, Inc. All rights reserved.